ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,670,871 | -21.7% | 609,212 | -5.4% | 0.00% | -50.0% |
| Q2 2023 | $8,522,125 | +42.9% | 643,665 | +46.9% | 0.00% | +100.0% |
| Q1 2023 | $5,962,663 | -28.4% | 438,109 | +2.7% | 0.00% | -50.0% |
| Q4 2022 | $8,329,760 | +27.2% | 426,511 | +24.1% | 0.00% | 0.0% |
| Q3 2022 | $6,546,000 | -22.7% | 343,601 | -16.4% | 0.00% | 0.0% |
| Q2 2022 | $8,468,000 | +43.7% | 411,071 | +124.5% | 0.00% | +100.0% |
| Q1 2022 | $5,893,000 | +7.9% | 183,141 | +56.1% | 0.00% | 0.0% |
| Q4 2021 | $5,462,000 | +15.4% | 117,304 | -33.1% | 0.00% | 0.0% |
| Q3 2021 | $4,733,000 | +52.2% | 175,284 | +44.5% | 0.00% | 0.0% |
| Q2 2021 | $3,110,000 | +36.7% | 121,274 | +82.2% | 0.00% | 0.0% |
| Q1 2021 | $2,275,000 | +10.9% | 66,551 | +9.7% | 0.00% | 0.0% |
| Q4 2020 | $2,051,000 | +214.6% | 60,659 | +129.5% | 0.00% | – |
| Q3 2020 | $652,000 | – | 26,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |